V
Vistin Pharma ASA
OSE:VISTN
Vistin Pharma ASA
OSE:VISTN
Price:
20.7
NOK
-0.96%
Market Cap:
kr917.8m
Relative Value
The Relative Value of one VISTN stock under the Base Case scenario is hidden NOK. Compared to the current market price of 20.7 NOK, Vistin Pharma ASA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VISTN Relative Value
HIDDEN
Multiples Across Competitors
VISTN Competitors Multiples
Vistin Pharma ASA Competitors
Vistin Pharma ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
V
|
Vistin Pharma ASA
OSE:VISTN
|
917.9m NOK | 2 | 11.8 | 8 | 9.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.7 | 57 | 38.2 | 41 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.5B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.5 | 16.2 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.5B GBP | 5.1 | 31.5 | 15 | 22 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.2 | 12.9 | 9 | 10.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 2.4 | 19.4 | 6.9 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
